Colesevelam Improves Glycemic Control in Type 2 Diabetes

CHICAGO — The cholesterol-lowering drug colesevelam HCl improves glycemic control in patients with type 2 diabetes who are inadequately controlled with metformin monotherapy, Dr. Harold E. Bays reported in a poster presentation at the annual scientific sessions of the American Diabetes Association.